Cambridge Innovation Capital has released the numbers for its performance during the first half of the financial year, boasting a rise in its portfolio's fair value to $116m.
Cambridge Innovation Capital (CIC), the patient capital fund affiliated with University of Cambridge, on Friday revealed the fair value of its portfolio has increased to £86m ($116m) during the first half of the financial year.
CIC, which announced the figures for the period ending September 30, noted that the value was up from £58.2m as of the end of March.
Its portfolio additions include Bicycle Therapeutics, which raised $52m in a series B round in June, and Prowler.io, which…
